Last reviewed · How we verify
NCT06946303
Identifying Key Attributes and Learning From a Local Falls Prevention Ambassador Programme
trial testing Survey in Long Term Care in 24 participants. Completed in 30 September 2025.
30 September 2025
Quick facts
| Lead sponsor | University of Nottingham |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 24 |
| Start date | 13 August 2024 |
| Primary completion | 30 September 2025 |
| Estimated completion | 30 September 2025 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Survey
- Interview
- Observation
Conditions studied
- Long Term Care — all drugs for Long Term Care →
Sponsor
University of Nottingham
Who can join
18 and older, any sex, with Long Term Care. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Managing falls for care home residents can be challenging for care home staff who work in complex settings and with residents with complex needs. Our previous research has identified that care homes would like more ongoing support and learning to improve their confidence in managing falls. One such programme is being set up in Lincolnshire. The Lincolnshire Care Association are setting up a falls ambassador programme designed to provide ongoing support and learning for care homes on falls management. Exploring what this programme involves, what topics are covered and identified by care homes and whether they feel more confident in managing falls will help other areas in setting up similar programmes. This research will explore the key attributes of the Lincolnshire Falls ambassador programme and explore whether it supports care home staff to feel more confident in managing falls by asking staff about their confidence before and after, observing the topics that are covered in the group meetings and by interviewing members of the programme after it has been established.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06946303
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Survey
Trials testing the same drug.
- NCT07452159 — Diabetes In Asians at Risk in Youth · not yet recruiting
- NCT07294703 — Factors Associated With Breast Cancer Risks and Outcomes · recruiting
- NCT07330739 — Kinesiophobia in Women With Stress Urinary Incontinence · active not recruiting
- NCT07215039 — Improving Prison Health Equity Through Cancer Literacy and Screening Awareness in Florida · enrolling by invitation
- NCT07220096 — Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Pati · recruiting
Other recruiting trials for Long Term Care
Currently open trials in the same condition.
- NCT07068009 — Training and Support Programme on Data-driven Quality Development for Swiss Long-Term Care Facilities (NIP-Q-UPGRADE Sub · NA · active not recruiting
Other University of Nottingham trials
Trials by the same sponsor.
- NCT07518381 — Medication Understanding in MS · not yet recruiting
- NCT07355556 — Technology Supported Improvement, Management and Prevention of Accidental Falls in Hospitals · not yet recruiting
- NCT07506408 — Randomised Study of Web-Based Auditory Training With Varying Perceptual and Cognitive Demands on Training Gains and Gene · NA · recruiting
- NCT07237529 — What is the Feasibility of Narrative Exposure Therapy (NET) for People Experiencing Psychosis? · NA · not yet recruiting
- NCT07237997 — Protein Supplementation During Dialysis (PROSED) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06946303 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Nottingham
- Last refreshed: 18 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06946303.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing